PLRX   $15.21  3.68% Market Closed After Close 15.1866 -0.15%

Pliant Therapeutics Inc
Total Cash 436.61M
totalCashPerShare 7.181
EBITDA -205.71M
Total Debt 60.23M
quickRatio 14.209
currentRatio 14.473
Total Revenue 0.00
debtToEquity 15.337
Revenue/Share 0.0
ROA -0.24531001
ROE -0.40055
grossProfits
freeCashflow -88.96M
operatingCashflow -136.89M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 474.84M
forwardPE -3.6509902
floatShares 46.82M
sharesOutstanding 60.80M
sharesShort 6.77M
sharesShortPriorMonth 7.33M
dateShortInterest
sharesPercentSharesOut 0.11%
heldPercentInsiders 0.03%
heldPercentInstitutions 1.17%
Short Ratio help_outline 19.72%
shortPercentOfFloat 0.11%
impliedSharesOutstanding
bookValue 6.499
Price To Book help_outline 2.27
earningsQuarterlyGrowth
netIncomeToCommon -185.40M
trailingEps -3.09%
forwardEps -4.04%
enterpriseToEbitda -2.31
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.97 3Q 2024
institutionsCount 219
lastUpdated Oct. 16, 2024, 9:48 p.m.